A. Groth

867 citations

25 papers · 626 indexed · h-index 12

Impact in

Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 5%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Antiplatelet Therapy and Cardiovascular Diseases

Papers in ⓘ

Family Practice 3
- Medication Adherence and Compliance 3
Endocrinology, Diabetes and Metabolism 6
- Diabetes Treatment and Management 6
- Diabetes Management and Research 5

Co-authors: Thomas Wilke (24 shared papers)Ulf Maywald (15 shared papers)S. Mueller (11 shared papers)M. Pfannkuche (4 shared papers)Roland Linder (3 shared papers)Frank Verheyen (3 shared papers)Rupert Bauersachs (2 shared papers)G. Breithardt (1 shared paper)
Journals: Value in Health (9 papers)Cardiovascular Diabetology (1 paper)Journal of Diabetes and its Complications (1 paper)Thrombosis and Haemostasis (1 paper)The Nephron journals/Nephron journals (1 paper)
Partner nations: Germany United Kingdom United States

In The Last Decade

A. Groth

24 papers receiving 612 citations

Peers

Countries citing papers authored by A. Groth

Since Specialization

Citations

This map shows the geographic impact of A. Groth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Groth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Groth more than expected).

Fields of papers citing papers by A. Groth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Groth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Groth. The network helps show where A. Groth may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Groth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Groth Line = papers co-authored together A. Groth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients EP Europace ·Thomas Wilke, A. Groth, S. Mueller, M. Pfannkuche, Frank Verheyen, Roland Linder, Ulf Maywald, Rupert Bauersachs, G. Breithardt	2012	267
2	Oral anticoagulation use by patients with atrial fibrillation in Germany Thrombosis and Haemostasis ·Thomas Wilke, A. Groth, S. Mueller, M. Pfannkuche, Frank Verheyen, Roland Linder, Ulf Maywald, Thomas Kohlmann, You‐Shan Feng, Günter Breithardt, Rupert Bauersachs	2012	98
3	Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German T2DM patients Journal of Diabetes and its Complications ·Thomas Wilke, Bjoern Boettger, Bjoern Berg, A. Groth, S. Mueller, Marc Botteman, Shengsheng Yu, Andreas Fuchs, Ulf Maywald	2015	49
4	Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis Diabetes Therapy ·Thomas Wilke, S. Mueller, A. Groth, Bjoern Berg, Andreas Fuchs, Mirko Sikirica, John Logie, Alan Martin, Ulf Maywald	2015	32
5	Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use Journal of Thrombosis and Thrombolysis ·Thomas Wilke, A. Groth, M. Pfannkuche, Oliver Harks, Andreas Fuchs, Ulf Maywald, Bernd Krabbe	2014	29
6	Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus Cardiovascular Diabetology ·Thomas Wilke, S. Mueller, A. Groth, Andreas Fuchs, Lisa Seitz, J Kienhöfer, Ulf Maywald, R Lundershausen, Martin Wehling	2015	21
7	How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus The European Journal of Health Economics ·Thomas Wilke, A. Groth, S. Mueller, Dallas Reese, Roland Linder, S. Ahrens, Frank Verheyen	2012	20
8	Real life treatment of diabetes mellitus type 2 patients: An analysis based on a large sample of 394,828 German patients Diabetes Research and Clinical Practice ·Thomas Wilke, A. Groth, Andreas Fuchs, Lisa Seitz, J Kienhöfer, R Lundershausen, Ulf Maywald	2014	17
9	Real-world biologic treatment and associated cost in patients with inflammatory bowel disease Zeitschrift für Gastroenterologie ·Alina Brandes, A. Groth, Fraence Gottschalk, Thomas Wilke, Boris A. Ratsch, Hans‐Dieter Orzechowski, Andreas Fuchs, Barthold Deiters, Bernd Bokemeyer	2019	17
10	Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs SHILAP Revista de lepidopterología ·A. Groth, Thomas Wilke, Simon Borghs, P Gille, Lars Joeres	2017	13
11	Primary data, claims data, and linked data in observational research: the case of COPD in Germany Respiratory Research ·S. Mueller, Fraence Gottschalk, A. Groth, Wilhelmine Meeraus, Maurice T. Driessen, Thomas Kohlmann, Thomas Wilke	2018	12
12	Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset PubMed ·S. Mueller, A. Groth, Stefan G. Spitzer, Anja Schramm, Andreas Pfaff, Ulf Maywald	2018	11
13	Healthcare Burden and Costs Associated with Urinary Tract Infections in Type 2 Diabetes Mellitus Patients: An Analysis Based on a Large Sample of 456,586 German Patients The Nephron journals/Nephron journals ·Thomas Wilke, Björn Böttger, Bjorn P. Berg, A. Groth, Marc Botteman, Shengsheng Yu, Andreas Fuchs, Ulf Maywald	2016	10
14	Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany Clinical Therapeutics ·Thomas Wilke, A. Groth, Gráinne H. Long, Amanda R. Tatro, Diana Sun	2019	8
15	Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients European Journal of Clinical Pharmacology ·Thomas Wilke, A. Groth, Andreas Fuchs, M. Pfannkuche, Ulf Maywald	2017	7
16	Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study Journal of Diabetes & Metabolic Disorders ·Thomas Wilke, S. Mueller, A. Groth, Bjoern Berg, Niklas Hammar, Katherine Tsai, Andreas Fuchs, Stephanie Stephens, Ulf Maywald	2015	3
17	Incidence and Prevalence of Epilepsy in Germany Value in Health ·A. Groth, Simon Borghs, P Gille, Lars Joeres, Thomas Wilke	2017	3
18	PGI1 - ADVERSE EVENTS ASSOCIATED WITH THE TREATMENT OF INFLAMMATORY BOWEL DISEASE IN GERMANY Value in Health ·Thomas Wilke, A. Groth, Gráinne H. Long, Amanda R. Tatro, Diana Sun	2018	2
19	Real-Life Autologous Stem Cell Transplantation and Overall Survival Rates in Newly Diagnosed Multiple Myeloma Patients: An Analysis Based on a German Claims Dataset Value in Health ·S. Mueller, Thomas Wilke, Ulf Maywald, A. Groth, T. Heidler, Bart Heeg	2018	1
20	Classification of Chronic Obstructive Pulmonary Disease (COPD) Severity According to the Global Initiative for Chronic Obstructive Lung Disease (Gold): Variations in the Defintion of Gold Groups and Their Impact on Stage Assignment Value in Health ·Frank Gottschalk, S. Mueller, A. Groth, Martin Drießen, Thomas Wilke	2017	1

About A. Groth

A. Groth is a scholar working on Family Practice, Endocrinology, Diabetes and Metabolism, Internal Medicine, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology, having authored 25 papers that have together received 626 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (6 papers), Diabetes Treatment and Management (6 papers), Diabetes Management and Research (5 papers), Cardiac Arrhythmias and Treatments (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical studies and practices (3 papers), Inflammatory Bowel Disease (3 papers) and Medication Adherence and Compliance (3 papers). The work is most often cited by research in Internal Medicine (117 citations), Cardiology and Cardiovascular Medicine (386 citations), Family Practice (31 citations), Endocrinology, Diabetes and Metabolism (82 citations) and Geriatrics and Gerontology (15 citations). A. Groth has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Thomas Wilke, Ulf Maywald, S. Mueller, M. Pfannkuche, Roland Linder, Frank Verheyen, Rupert Bauersachs, G. Breithardt, Andreas Fuchs and Thomas Kohlmann. Their work appears in journals such as Value in Health, Cardiovascular Diabetology, Journal of Diabetes and its Complications, Thrombosis and Haemostasis and The Nephron journals/Nephron journals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact